patent on semaglutide Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Semaglutide Canada: Generic Access on

Nothing in life is without risk, but I would also argue that the status quo is not safe for people who need the medicine and cant get it, he said

Its 2022 disclosure by Coskun and colleagues (Cell Metabolism) marked a deliberate extension of the dual-incretin agonist concept pioneered by tirzepatide, adding glucagon receptor engagement to the pharmacological palette

Among Lyra Healths 2024 predictions for mental health, the company tracked a dramatic spike upward in the proportion of benefits leaders who believed mental health benefits were very important to employee prospects: that sentiment rose from 36% of HR benefit leaders in 2022 up to 94% in 2023, signaling the mainstreaming of accepting and , we infer, addressing mental health needs of the workforce and families in the new year

Are GLP-1s the First Longevity Drugs